兽用整形外科市场－全球产业规模、份额、趋势、机会、预测：按动物类型、产品、应用、最终用户、地区和竞争格局划分，2021-2031年

全球兽医整形外科市场预计将从 2025 年的 5.8733 亿美元成长到 2031 年的 9.7852 亿美元，复合年增长率为 8.88%。

本产业涵盖用于治疗动物肌肉骨骼损伤、关节畸形和骨折的医疗设备、仪器和植入的製造和供应。推动该市场发展的关键因素包括伴侣动物中与老龄化相关的骨关节炎和肥胖症发病率的上升，以及宠物人性化趋势的日益增长，这反映了饲主对更高水平护理的需求不断增加。此外，兽医保险的普及为支付手术费用和维持对矫正治疗的需求提供了重要的结构性支持。

根据美国宠物用品协会（APPA）统计，2024年美国兽医护理及相关产品的销售额达到398亿美元，显示动物保健领域获得了大量资本投入，从而支撑了专业治疗市场的发展。儘管财务表现强劲，但市场扩张的主要障碍仍然是高昂的整形外科手术费用。这些费用限制了没有保险的宠物饲主获得医疗服务，也阻碍了价格敏感型发展中地区的市场渗透。

市场驱动因素

伴侣动物肥胖和肌肉骨骼疾病的日益增加是推动市场扩张的主要因素。这是因为超重会显着加剧关节退化，并增加前十字韧带断裂等损伤的风险。这种生理关联确保了需要手术器械和骨科植入的病例持续不断。根据英国宠物食品协会于2024年10月发布的《2024年肥胖报告》的数据，50%的犬和43%的猫被归类为肥胖或超重，这凸显了这场健康危机如何直接推动了对整形外科手术的需求。此外，全国保险公司于2024年4月发布的《最常见疾病报告》证实，骨关节炎仍然是投保宠物中最常见的疾病之一，强调了对有效的肌肉骨骼干预和管理的广泛临床需求。

同时，报销政策的调整和宠物健康保险的扩展正在从根本上改变市场动态，使更多人能够负担得起先进的整形外科手术。保险降低了饲主的自付费用，使微创骨折修復和全髋关节置换术等昂贵的治疗更容易获得。这种结构性变化在产业的财务表现中得到了清楚的体现。例如，Trupanion在2024年2月发布的2023年第四季及全年财报中显示，其总收入年增22%，凸显了投保人数的快速增长，从而支撑了对专业兽医护理的持续投入。

市场挑战

高昂的先进整形外科手术费用是全球兽医整形外科市场扩张的主要障碍。十字韧带修復和全髋关节置换术等复杂手术需要专业的外科技术、昂贵的设备以及长期的术后康復，其费用往往令没有保险的宠物饲主难以负担。这种经济障碍实际上将市场限制在高所得群体，迫使很大一部分潜在客户选择安宁疗护或保守治疗，而非手术方案。因此，手术器械的采购和植入的使用仍然受到限制，尤其是在动物医疗保健自由裁量权有限的新兴经济体。

这种价格敏感性导致兽医服务消费大幅萎缩，直接影响整形外科领域。根据美国兽医协会（AVMA）预测，由于饲主难以应付不断上涨的医疗成本，2024年兽医总支出将年减4%。现金流的减少表明，经济压力迫使宠物饲主优先考虑基本服务而非昂贵的专科手术，导致整形外科设备製造商的收入成长放缓，并阻碍了其市场渗透。

市场趋势

肢体保留技术和全关节置换术的进步正在从根本上改变临床疗效，并将市场重心从简单的骨折固定转向复杂的修復解决方案。这一趋势包括客製化植入和模组化关节系统的开发，使外科医生能够治疗以前被认为无法治癒的严重退化性疾病和发育不良。业界对这些专业创新的关注体现在产品开发的快速步伐上。根据Vimian集团于2024年2月发布的财年终报告，该公司在该财年推出了111款新产品，积极拓展产品系列，以满足整形外科等专科领域尚未满足的医疗需求。这种对研发的高度重视确保了先进挽救性手术所需精密器械的持续供应。

人工智慧驱动的术前手术规划工具的应用正成为提高效率的关键驱动因素。这使得兽医能够自动分析诊断影像，从而实现精确的轨迹建模和植入尺寸选择。将人工智慧整合到放射科工作流程中，可以帮助骨科医生显着缩短准备时间，提高矫正性截骨术的精准度，并实现更高的手术可重复性和更低的术中风险。这种数位化转型正在改变临床实践。根据Digitail和美国动物医院协会（AAHA）于2024年2月发布的《兽医学中的人工智慧》报告，39.2%的兽医专业人员在其工作中使用人工智慧工具，其中诊断影像和放射学是主要应用领域。这提高了手术结果的可预测性，并有助于应对转诊和基层医疗机构中日益复杂的整形外科手术。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球兽医整形外科市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 动物种类（狗、猫、其他）
  • 副产品（植入、器械）
  • 依应用领域（TPLO、TTA、关节重建、创伤、其他）
  • 依最终使用者（兽医院/诊所、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美兽医整形外科市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲兽医整形外科市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区兽医整形外科市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲兽医整形外科市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲兽医整形外科市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球兽医整形外科市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• B. Braun SE
• Vimian Group AB
• Integra LifeSciences Corporation
• AmerisourceBergen Corporation
• Arthrex, Inc.
• Orthomed（UK）Limited
• Animal Healthcare Services Ltd
• Narang Medical Limited
• Fusion Implants
• Medical Device Business Services, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Veterinary Orthopedics Market is projected to expand from USD 587.33 Million in 2025 to USD 978.52 Million by 2031, registering a CAGR of 8.88%. This industry sector encompasses the manufacture and supply of medical devices, instruments, and implants designed to treat musculoskeletal trauma, joint deformities, and bone fractures in animals. Major drivers fueling this market include the rising incidence of age-related osteoarthritis and obesity in companion animals, alongside the growing trend of pet humanization which raises the standard of care expected by owners. Furthermore, the increasing availability of veterinary health insurance provides essential structural support by offsetting surgery costs and maintaining demand for corrective procedures.

According to the American Pet Products Association, sales of veterinary care and products in the United States totaled $39.8 billion in 2024, demonstrating significant capital investment in the animal health sector that bolsters specialized treatment markets. Despite this robust financial performance, a major obstacle hindering wider market growth is the high expense associated with advanced orthopedic interventions. These costs limit accessibility for pet owners who lack insurance coverage and restrict market penetration in developing regions where price sensitivity is more pronounced.

Market Driver

The increasing prevalence of obesity and musculoskeletal disorders in companion animals serves as a major catalyst for the market, as excess weight significantly worsens joint degeneration and increases susceptibility to injuries such as cranial cruciate ligament ruptures. This physiological connection guarantees a consistent volume of cases necessitating surgical instrumentation and corrective implants. Data from UK Pet Food's 'Obesity Report 2024', released in October 2024, indicates that 50% of dogs and 43% of cats are classified as obese or overweight, underscoring a health crisis that directly fuels the orthopedic surgical pipeline. Moreover, Nationwide's 'Most Common Medical Conditions' report from April 2024 confirms that osteoarthritis remains one of the most frequent conditions affecting insured pets, reinforcing the widespread clinical need for effective musculoskeletal intervention and management.

Concurrently, the rising adoption of reimbursement policies and pet health insurance is fundamentally transforming market dynamics by rendering sophisticated orthopedic procedures financially feasible for a larger demographic. Expensive interventions, such as minimally invasive fracture repairs and total hip replacements, are becoming more accessible as insurance reduces the out-of-pocket expenses for owners. This structural change is evident in the sector's financial performance; for example, Trupanion reported a 22% increase in total revenue year-over-year in its 'Fourth Quarter and Full Year 2023 Results' from February 2024, highlighting the rapid growth of the insured population that supports sustained spending on specialized veterinary healthcare.

Market Challenge

The substantial costs linked to advanced orthopedic interventions create a significant barrier to the scalability of the Global Veterinary Orthopedics Market. Complex procedures like cruciate ligament repairs and total hip replacements demand specialized surgical skills, expensive instrumentation, and extensive post-operative rehabilitation, resulting in price points that are often prohibitive for uninsured pet owners. This economic hurdle effectively limits the market's reach to higher-income demographics, compelling a large segment of the potential client base to opt for palliative care or conservative medical management instead of surgical solutions. Consequently, the procurement of surgical instruments and implant utilization remain suppressed, particularly in emerging economies with lower discretionary spending on animal healthcare.

This sensitivity to price has caused a tangible contraction in the consumption of veterinary services, directly impacting the orthopedics sector. According to the American Veterinary Medical Association (AVMA), overall veterinary spending decreased by 4% in 2024 compared to the prior year as owners struggled with escalating care costs. This reduction in capital flow illustrates how financial constraints force pet owners to prioritize essential services over high-cost specialized procedures, thereby dampening the revenue growth for orthopedic device manufacturers and impeding broader market penetration.

Market Trends

Advancements in limb-sparing technologies and total joint replacement are fundamentally changing clinical outcomes, shifting the market focus from simple fracture fixation to complex restorative solutions. This trend involves the development of custom-manufactured implants and modular prosthetic systems that enable surgeons to treat severe degenerative conditions and dysplasia that were previously considered untreatable. The industry's dedication to these specialized innovations is highlighted by the rapid pace of product development; according to Vimian Group's 'Year-end Report 2023' from February 2024, the company commercialized 111 new products during the fiscal year, aggressively expanding its portfolio to address unmet medical needs in specialized sectors like orthopedics. This strong emphasis on R&D guarantees a continuous supply of sophisticated instrumentation needed for high-level salvage procedures.

The adoption of AI-driven preoperative surgical planning tools is emerging as a vital efficiency driver, allowing veterinarians to automate the analysis of diagnostic imaging for precise trajectory modeling and implant sizing. By integrating artificial intelligence into radiographic workflows, orthopedic surgeons can significantly reduce preparation time and improve the accuracy of corrective osteotomies, thereby enhancing reproducibility and mitigating intraoperative risks. This digital shift is reshaping practice operations; as reported by Digitail and the American Animal Hospital Association (AAHA) in their 'AI in Veterinary Medicine' report from February 2024, 39.2% of veterinary professionals utilize AI tools in clinical settings, with imaging and radiology cited as primary applications. This facilitates more predictable surgical outcomes and supports the increasing complexity of orthopedic interventions offered at both referral and primary care levels.

Key Market Players

• B. Braun SE
• Vimian Group AB
• Integra LifeSciences Corporation
• AmerisourceBergen Corporation
• Arthrex, Inc.
• Orthomed (UK) Limited
• Animal Healthcare Services Ltd
• Narang Medical Limited
• Fusion Implants
• Medical Device Business Services, Inc.

Report Scope

In this report, the Global Veterinary Orthopedics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Orthopedics Market, By Animal Type

• Canine
• Feline
• Others

Veterinary Orthopedics Market, By Product

• Implants
• Instruments

Veterinary Orthopedics Market, By Application

• TPLO
• TTA
• Joint Replacement
• Trauma
• Others

Veterinary Orthopedics Market, By End User

• Veterinary Hospitals & Clinics
• Others

Veterinary Orthopedics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Orthopedics Market.

Available Customizations:

Global Veterinary Orthopedics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Orthopedics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Canine, Feline, Others)
  • 5.2.2. By Product (Implants, Instruments)
  • 5.2.3. By Application (TPLO, TTA, Joint Replacement, Trauma, Others)
  • 5.2.4. By End User (Veterinary Hospitals & Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Veterinary Orthopedics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Orthopedics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Veterinary Orthopedics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Veterinary Orthopedics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Veterinary Orthopedics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Veterinary Orthopedics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Veterinary Orthopedics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Veterinary Orthopedics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Veterinary Orthopedics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Veterinary Orthopedics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Veterinary Orthopedics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Veterinary Orthopedics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Veterinary Orthopedics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Veterinary Orthopedics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Veterinary Orthopedics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Veterinary Orthopedics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Veterinary Orthopedics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Veterinary Orthopedics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Veterinary Orthopedics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Veterinary Orthopedics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Veterinary Orthopedics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Veterinary Orthopedics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Veterinary Orthopedics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Veterinary Orthopedics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Veterinary Orthopedics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. B. Braun SE
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Vimian Group AB
• 15.3. Integra LifeSciences Corporation
• 15.4. AmerisourceBergen Corporation
• 15.5. Arthrex, Inc.
• 15.6. Orthomed (UK) Limited
• 15.7. Animal Healthcare Services Ltd
• 15.8. Narang Medical Limited
• 15.9. Fusion Implants
• 15.10. Medical Device Business Services, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer